You are here:
Home
NICE Guidance
Conditions and diseases
Infections
HIV and AIDS
Doravirine–islatravir for treating HIV-1 in people with virological suppression on bictegravir, emtricitabine and tenofovir alafenamide combination treatment [TSID12171]
Topic selection
Project information
Project documents
37507-Doravirine-islatravir-for-HIV-1-infection-V1.0-JAN2025-NON-CONF.pdf
Back to top